165 related articles for article (PubMed ID: 27992120)
1. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.
Achilles A; Mohring A; Dannenberg L; Grandoch M; Hohlfeld T; Fischer JW; Levkau B; Kelm M; Zeus T; Polzin A
J Thromb Haemost; 2017 Mar; 15(3):473-476. PubMed ID: 27992120
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy.
Sokol J; Nehaj F; Ivankova J; Mokan M; Mokan M; Stasko J
Scand Cardiovasc J; 2018 Aug; 52(4):227-231. PubMed ID: 29842807
[TBL] [Abstract][Full Text] [Related]
3. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y
Whitley MJ; Henke DM; Ghazi A; Nieman M; Stoller M; Simon LM; Chen E; Vesci J; Holinstat M; McKenzie SE; Shaw CA; Edelstein LC; Bray PF
J Thromb Haemost; 2018 Dec; 16(12):2501-2514. PubMed ID: 30347494
[TBL] [Abstract][Full Text] [Related]
4. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
5. TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
Olivier CB; Weik P; Meyer M; Weber S; Anto-Michel N; Diehl P; Zhou Q; Geisen U; Bode C; Moser M
Thromb Res; 2016 Feb; 138():63-68. PubMed ID: 26610745
[TBL] [Abstract][Full Text] [Related]
6. Vascular protease-activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long-term dabigatran administration - results from a diabetes animal model.
Scridon A; Mărginean A; Huțanu A; Chinezu L; Gheban D; Perian M; Vântu A; Gherțescu D; Fișcă PC; Șerban RC; Chevalier P; Dobreanu D
J Thromb Haemost; 2019 Mar; 17(3):538-550. PubMed ID: 30653813
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of ACE inhibition-associated enhanced platelet reactivity: disproof of the ARB-MI paradox?
Helten C; Mourikis P; Dannenberg L; M'Pembele R; Trojovsky K; Ayhan A; Kohlmorgen C; Grandoch M; Levkau B; Veulemans V; Petzold T; Hohlfeld T; Kelm M; Zeus T; Polzin A
Eur J Clin Pharmacol; 2020 Sep; 76(9):1245-1251. PubMed ID: 32500252
[TBL] [Abstract][Full Text] [Related]
8. Thrombin Receptor Agonist Peptide-Induced Platelet Aggregation Is Reduced in Patients Receiving Dabigatran.
Nehaj F; Sokol J; Mokan M; Ivankova J; Mokan M
Clin Appl Thromb Hemost; 2018 Mar; 24(2):268-272. PubMed ID: 28703014
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: reply.
Achilles A; Mohring A; Zeus T; Kelm M; Polzin A
J Thromb Haemost; 2017 Jul; 15(7):1524-1525. PubMed ID: 28445598
[No Abstract] [Full Text] [Related]
10. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: comment.
Bonello L; Laine M; Camoin-Jau L; Frere C
J Thromb Haemost; 2017 Jul; 15(7):1522-1523. PubMed ID: 28426920
[No Abstract] [Full Text] [Related]
11. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
[TBL] [Abstract][Full Text] [Related]
12. The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers.
Zemer-Wassercug N; Haim M; Leshem-Lev D; Orvin KL; Vaduganathan M; Gutstein A; Kadmon E; Mager A; Kornowski R; Lev EI
J Thromb Thrombolysis; 2015 Oct; 40(3):340-6. PubMed ID: 26184605
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-induced Akt activation--regulation and possible function.
Reséndiz JC; Kroll MH; Lassila R
J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
[TBL] [Abstract][Full Text] [Related]
14. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
Norman JE; Cunningham MR; Jones ML; Walker ME; Westbury SK; Sessions RB; Mundell SJ; Mumford AD
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):952-60. PubMed ID: 26966273
[TBL] [Abstract][Full Text] [Related]
15. Influence of PAR-1 in patients with non-valvular atrial fibrillation: The antiplatelet effect of dabigatran.
Oi K; Shimizu M; Natori T; Tsuda K; Yoshida M; Kamada A; Ishigaku Y; Narumi S; Oura K; Maeda T; Terayama Y
Thromb Res; 2021 May; 201():123-130. PubMed ID: 33667955
[TBL] [Abstract][Full Text] [Related]
16. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
17. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
19. [Role of adenosine diphosphate in the course of thrombin signal transmission].
Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
[TBL] [Abstract][Full Text] [Related]
20. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
